Skip to main content

Table 2 Predictors of attendance to the HIV cervical cancer screening program in WLWH 1 aged 30, 40 and 50 years

From: Adherence to the cervical cancer screening program in women living with HIV in Denmark: comparison with the general population

Predictors of attendance in different age groups

30 years (n = 386)

40 years (n = 555)

50 years (n = 214)

 

n (%) attending screening

Unadjusted

Adjusted

n (%) attending screening

Unadjusted

Adjusted

n (%) attending screening

Unadjusted

Adjusted

Mode of transmission,

Heterosexual contact

124 (45.4)

1.00‡

1.00‡

177 (45.9)

1.00‡

1.00‡

72 (50.0)

1.00‡

1.00‡

Intravenous drug use

11 (44.0)

0.94 (0.41-2.15)

0.77 (0.31-1.92)

19 (35.2)

0.64 (0.35-1.16)

0.64 (0.33-1.23)

10 (43.5)

0.77 (0.32-1.87)

0.91 (0.34-2.45)

Other

2 (33.3)

0.60 (0.11-3.35)

0.48 (0.08-2.77)

4 (33.3)

0.59 (0.18-1.99)

0.52 (0.15-1.78)

2 (66.7)

2.00 (0.18-22.55)

1.93 (0.16-22.57)

(missing)

(82)

  

(103)

  

(44)

  

Race,

White

51 (48.6)

1.00‡

1.00‡

95 (47.7)

1.00‡

1.00‡

46 (46.5)

1.00‡

1.00‡

Asian

22 (38.6)

0.67 (0.35-1.28)

0.51 (0.25-1.07)

24 (48.0)

0.99 (0.53-1.84)

0.93 (0.48-1.80)

7 (58.3)

1.61 (0.48-5.43)

1.66 (0.42-6.57)

Black

65 (43.9)

0.83 (0.50-1.37)

0.75 (0.43-1.32)

87 (42.2)

1.25 (0.84-1.85)

0.72 (0.47-1.12)

29 (50.0)

1.15 (0.60-2.20)

0.90 (0.43-1.86)

Other

4 (57.1)

1.41 (0.30-6.62)

1.22 (0.25-5.96)

5 (31.3)

2.01 (0.67-5.99)

0.49 (0.14-1.64)

3 (60.0)

1.73 (0.28-10.80)

0.87 (0.11-6.57)

(missing)

(69)

  

(84)

  

(40)

  

Calendar period

01.01.2002 – 31.12.20022

47 (37.0)

1.00‡

1.00‡

35

1.00‡

1.00‡

5 (55.6)

1.00‡

1.00‡

01.01.2003 – 31.12.2010

99 (38.2)

1.05 (0.68-1.63)

0.97 (0.59-1.62)

(35.0)176 (38.7)

1.17 (0.75-1.84)

1.00 (0.59-1.67)

81 (39.5)

0.52 (0.14-2.00)

0.39 (0.07-2.11)

Time-updated HIV RNA (copies/mL)

>500

48 (27.8)

1.00†

1.00†

43 (26.9)

1.00†

1.00†

12 (26.1)

1.00†

1.00‡

<500

96 (47.3)

2.34 (1.52-3.60)

2.06 (1.27-3.33)

165 (43.2)

2.07 (1.38-3.10)

1.87 (1.18-2.97)

73 (45.6)

2.38 (1.15-4.92)

2.21 (0.98-4.99)

(missing)

(10)

  

(13)

  

(8)

  

Time-updated CD4 count (cells/μL)

< 200

11 (19.3)

1.00†

1.00†

16 (23.9)

1.00†

1.00‡

6 (25.0)

1.00†

1.00†

200–350

31 (36.9)

2.45 (1.11-5.41)

2.48 (1.06-5.76)

34 (32.4)

1.53 (0.76-3.06)

1.17 (0.55-2.49)

8 (24.2)

0.96 (0.28-3.25)

0.61 (0.16-2.42)

> 350

102 (43.2)

3.18 (1.57-6.45)

3.02 (1.42-6.42)

159 (42.9)

2.39 (1.32-4.35)

1.58 (0.82-3.05)

71 (47.3)

2.69 (1.01-7.17)

2.41 (0.79-7.33)

(missing)

(9)

  

(12)

  

(7)

  
  1. Unadjusted and adjusted odds ratios (OR’s) for predictors of attendance. Predictors of attendance to the cervical screening program in different age groups were estimated including the month observed closest to 30, 40 and 50 years (+/- 3 years) to determine whether or not the woman was covered by screening. Two models are shown in the table: Mode of transmission, ethnicity and calendar period were included in both models, whereas time-updated HIV RNA was included in the first model and replaced by CD4 count in the second model. We only presented the OR of the CD4 count from the second model. 1Women living with HIV (WLWH). 2Since no data was available before 1999 the reference period only included 2002 to allow for three years observation before initiation.
  2. †The simultaneous test was significant. ‡The simultaneous test was insignificant.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us